News
Semaglutide improved maximum walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback